Genetic differences in behavioral sensitivity to a neuroactive steroid

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 820-828

  Finn, Deborah A ^a,c   Roberts, Amanda J ^a,b   Lotrich, Frank ^a   Gallaher, Edward J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CHLORDIAZEPOXIDE; PENTETRAZOLE; PHENOBARBITAL;

ADOLESCENT; ALCOHOL WITHDRAWAL; ANTICONVULSANT ACTIVITY; ARTICLE; ATAXIA; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; GENETIC HETEROGENEITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; STRAIN DIFFERENCE;

ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ATAXIA; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MOTOR ACTIVITY; MUSCLE RELAXATION; PENTYLENETETRAZOLE; PREGNANOLONE; SEIZURES; SPECIES SPECIFICITY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031000138     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. BELELLI, D., BOLGER, M. B. AND GEE, K. W.: Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur. J. Pharmacol. 166: 325-329, 1989.
2. BELELLI, D., LAN, N. C. AND GEE, K. W.: Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci. Biobaehav. Rev. 14: 315-322, 1990.
3. A receptor. Brain Res. 561: 157-161, 1991.
4. BRITTON, K. T., PAGE, M., BALDWIN, H. AND KOOB, G. F.: Anxiolytic activity of steroid anesthetic alphaxalone. J. Pharmacol. Exp. Ther. 258: 124-129, 1991.
5. COLE, J. C. AND RODGERS, R. J.: Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: Comparison with haloperidol. Psychopharmacology 114: 288-296, 1994.
6. CORPECHOT, C., YOUNG, J., CALVEL, M., WEHREY, C., VELTZ, J. N., TOUYER, G., MOUREN, M., PRASAD, V. V. K., BANNER, C., SJOVALL, J., BAULIEU, E. E. AND ROBEL, P.: Neurosteroids: 3α-hydroxy-5α-pregnan-20-one and its precursors in the brain, plasma and steroidogenic glands of male and female rats. Endocrinology 133: 1003-1009, 1993.
7. CRABBE, J. C., JR., YOUNG, E. R. AND KOSOBUD, A.: Genetic correlations with ethanol withdrawal severity. Pharmacol. Biochem. Behav. 18: suppl. 1, 541-547, 1983.
8. CRAWLEY, J. N., GLOWA, J. R., MAJEWSKA, M. D. AND PAUL, S. M.: Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398: 382-385, 1986.
9. DUNHAM, N. W. AND MIYA, T. S.: A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46: 208-209, 1957.
10. FERRARO, T. N., GOLDEN, G. T., SMITH, G. G. AND BERRETTINI, W. H.: Differential susceptibility to seizures induced by systemic kainic acid treatment in mature DBA/2J and C57BL/6J mice. Epilepsia 36: 301-307, 1995.
11. FINN, D. A., CRABBE, J. C., MERRILL, C., YOUNG, E., LOTRICH, F., JONES, G. AND GALLAHER, E. J.: Genetic differences in sensitivity to a neuroactive steroid. Alcohol. Clin. Exp. Res. 19: 11A, 1995a.
12. FINN, D. A. AND GEE, K. W.: The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J. Pharmacol. Exp. Ther. 271: 164-170, 1994.
13. FINN, D. A., ROBERTS, A. J. AND CRABBE, J. C.: Neuroactive steroid sensitivity in Withdrawal Seizure Prone and Resistant mice. Alcohol. Clin. Exp. Res. 19: 410-415, 1995b.
14. FINN, D. A., ROBERTS, A. J., KEITH, L. D., MERRILL, C., YOUNG, E. AND CRABBE, J. C.: Chronic ethanol differentially alters neurosteroids in Withdrawal Seizure Prone and Resistant mice. Alcohol. Clin. Exp. Res. 18: 448, 1994.
15. FORDYCE, D. E. AND WEHNER, J. M.: Physical activity enhances spatial learning performance with an associated alteration in hippocampal protein kinase C activity in C57BL/6 and DBA/2 mice. Brain Res. 619: 111-119, 1993.
16. GALE, K.: Progression and generalization of seizure discharge: Anatomical and neurochemical substrates. Epilepsia 29: suppl. 2, S15-S34, 1988.
17. A receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation. Mol. Pharmacol. 40: 995-999, 1991.
18. HARRISON, N. L. AND SIMMONDS, M. A.: Modulation of the GABA receptor complex by a steroid anesthetic. Brain Res. 323: 287-292, 1984.
19. KOKATE, T. G., SVENSSON, B. J. AND ROGAWSKI, M. A.: Anticonvulsant activity of neurosteroids: Correlation with γ-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther. 270: 1223-1229, 1994.
20. KOSOBUD, A. E. AND CRABBE, J. C.: Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs. Brain Res. 526: 8-16, 1990.
21. A receptor function. Trends Pharmacol. Sci. 16: 295-303, 1995.
22. A receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J. Neurosci. 12: 1063-1076, 1992.
23. LHOTELLIER, L., PEREZ-DIAZ, F. AND COHEN-SALMON, C.: Locomotor and exploratory activity in three inbred strains of mice from young adulthood to senescence. Exp. Aging Res. 19: 177-187, 1993.
24. LISTER, R. G.: The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92: 180-185, 1987.
25. MENDELSON, W. B., MARTIN, J. V., PERLIS, M., WAGNER, R., MAJEWSKA, M. D. AND PAUL, S. M.: Sleep induction by an adrenal steroid in the rat. Psychopharmacology 93: 226-229, 1987.
26. MEYER, O. A., TILSON, H. A., BYRD, W. C. AND RILEY, M. T.: A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav. Toxicol. 1: 233-236, 1979.
27. MOK, W. M., HERSCHKOWITZ, S. AND KRIEGER, N. R.: In vivo studies identify 5α-pregnan-3α-ol-20-one as an active anesthetic agent. J. Neurochem. 57: 1296-1301, 1991.
28. MONTGOMERY, K. C.: The relation between fear induced by novel stimulation and exploratory behavior. J. Comp. Physiol. Psychol. 48: 254-260, 1958.
29. MORROW, A. L., SUZDAK, P. D. AND PAUL, S. M.: Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur. J. Pharmacol. 142: 483-485, 1987.
30. PAUL, S. M. AND PURDY, R. H.: Neuroactive steroids, FASEB J. 6: 2311-2322, 1992.
31. PELLOW, S., CHOPIN, P., FILE, S, E. AND BRILEY, M.: Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14: 149-167, 1985.
32. PHILLIPS, T. J. AND CRABBE, J. C.: Behavioral studies of genetic differences in alcohol action. In The Genetic Basis of Alcohol and Drug Actions, ed. by J. C. Crabbe, Jr. and R. A. Harris, pp. 25-104, Plenum Press, New York, 1991.
33. PURDY, R. H., MOORE, P. K., Jr., RAO, N., HAGINO, N., YAMAGUCHI, T., SCHMIDT, P., RUBINOW, D. R., MORROW, A. L. AND PAUL, S. M.: Radioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma. Steroids 55: 290- 296, 1990.
34. ROBERTS, A. J., CRABBE, J. C. AND KEITH, L. D.: Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal. Brain Res. 596: 296-302, 1992.
35. ROSSI-ARNAUD, C. AND AMMASSARI-TEULE, M.: Radial maze performance in inbred mice: Evidence for strain-dependent neural nets subserving spatial learning abilities. Psychobiology 22: 320-327, 1994.
36. A receptors in rat brain. J. Pharmacol. Exp. Ther. 262: 801-808, 1992.
37. SEYLE, H.: Correlation between the chemical structure and the pharmacological actions of the steroids. Endocrinology 30: 437-453, 1942.
38. TRULLAS, R. AND SKOLNICK, P.: Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology 111: 323-331, 1993.
39. A receptor-chloride ion channel complex. Neuropsychopharmacology 4: 9-15, 1991.
40. WEILAND, S., BELLUZZI, J. D., STEIN, L. AND LAN, N. C.: Comparative behavioral characterization of the neuroactive steroids 3α-OH,5α-pregnan-20-one and 3α-OH,5β-pregnan-20-one in rodents. Psychopharmacology 118: 65-71, 1995.
41. WEILAND, S., LAN, N. C., MIRASEDEGHI, S. AND GEE, K. W.: Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res. 565: 263-268, 1991.
42. A receptor subunit mRNAs in the rat brain, I. Telencephalon diencephalon, mesencephalon. J. Neurosci. 12: 1040-1062, 1992.